How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,242 results for

HIPAA

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Revised ATA guidelines for the management of medullary thyroid carcinoma

Carcinoembryonic antigen CLA Cutaneous lichen amyloidosis CRH Corticotropin-releasing hormone CT Computed tomography (tomographic) Ctn Calcitonin EBRT a External beam radiation therapy EMA European Medicines Agency FDA U.S. Food and Drug Administration FDG-PET 2-[Fluorine-18]?uoro-2-deoxy-D-glucose- positron emission tomography F-DOPA 18 F-dihydroxyphenylalanine FMTC Familial medullary thyroid cancer FNA Fine-needle aspiration FTC Follicular thyroid carcinoma HD Hirschsprung’s disease HIPAA Health Insurance

2015 Pediatric Endocrine Society

82. Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion

that includes continuous quality improve- ment (CQI) assessments and participa- tion in pro?ciency testing for all laboratory testing procedures. The laboratory must maintain documentation of all activities that are conducted within the laboratory. These include current policy and pro- cedure manuals as well as manuals or documentation of laboratory safety, infection control, disaster plans, Health Insurance Portability and Accountability Act (HIPAA) proce- dures, chemical hygiene, and labora- tory (...) for compliance with HIPAA requirements, the chain of custody for specimen trackingandhandling,timelyreportingofresults,identi?ca- tion of outlying or out-of-bounds results to the supervisor, and informing the director of any pro?ciency testing, QC, or CQI issues that do not meet laboratory standards. Laboratoriesshouldhaveaprocedureforspecimenlog-in with the appropriate information on the specimen to allow identi?cationofthesamplesourceaswellasthesamplerecip- ient (if applicable). The laboratory must

2014 Society for Assisted Reproductive Technology

84. Effective Patient?Physician Communication

Institutes of Health Consensus Development Conference Panel. Obstet Gynecol 2010;115:1279–95. de Haes H. Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Educ Couns 2006;62:291–8. Patient safety and the electronic health record. Committee Opinion No. 472. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:1245–7. Department of Health and Human Services, Office for Civil Rights. Does the HIPAA Privacy Rule permit health care providers

2014 American College of Obstetricians and Gynecologists

85. The Role of Worksite Health Screening

into account the complex legal requirements for protecting an individual employee’s personal health information. Assuring the use of worksite health screening or health and wellness program information does not result in employment discrimination is also an important consideration. Key laws applicable to information generated in health and wellness programs include the following: (1) the Health Insurance Portability and Accountability Act of 1996, as amended, and its accompanying regulations (HIPAA), (2 (...) ) the Genetic Information Nondiscrimination Act of 2008, (3) the Americans with Disabilities Act (ADA) of 1990, , the Employee Retirement Income Security Act (ERISA), and (4) state laws. HIPAA HIPAA is the most comprehensive law governing the use of personal health information. It applies to “covered entities” as defined in the statute. , A worksite health screening or health and wellness program is subject to HIPAA if it is part of an employer group health plan as defined by HIPAA. Under HIPAA, personal

2014 American Heart Association

87. Routine Human Immunodeficiency Virus Screening

. [ ] [ ] Guttmacher Institute. An overview of minors’ consent law. State Policies in Brief. New York (NY): GI; 2013. Available at: . Retrieved November 4, 2013. English A, Ford CA. The HIPAA privacy rule and adolescents: legal questions and clinical challenges. Perspect Sex Reprod Health 2004;36:80–6. [ ] [ ] Greenwald JL, Burstein GR, Pincus J, Branson B. A rapid review of rapid HIV antibody tests. Curr Infect Dis Rep 2006;8:125–31. [ ] Tepper NK, Farr SL, Danner SP, Maupin R, Nesheim SR, Cohen MH, et al. Rapid

2014 American College of Obstetricians and Gynecologists

88. Adolescent Confidentiality and Electronic Health Records

. In 2002, a federal rule was enacted that protects the privacy of individuals’ health records. The privacy rule, which is based on requirements contained in the Health Insurance Portability and Accountability Act (HIPAA) of 1996 provides protection against parents’ access to protected health information for adolescents aged 18 years and older; emancipated minors, minors who can legally consent to services or receive services without parental consent or notification according to state or other (...) applicable law; or when a parent assents to an agreement of confidentiality between the minor adolescent and health care provider. The HIPAA privacy rule, however, defers to state and other applicable laws (such as legislation governing Title X and Medicaid or precedent case law) about disclosure of protected health information for unemancipated minors, which may allow health care providers’ discretion regarding parental access to a minor’s protected health information ( ). The compromise struck

2014 American College of Obstetricians and Gynecologists

89. Developing and Evaluating Methods for Record Linkage and Reducing Bias in Patient Registries

information in these files. For additional assistance, please . Excerpt Health registries greatly enhance health services research, especially when linked with other data sources such as administrative claims. Recently, concerns about patient privacy and data security have produced policies such as the Health Insurance Portability and Accountability Act (HIPAA) that reduce the availability of sensitive identifying information. In this context, the development of effective record linkage approaches

2014 Effective Health Care Program (AHRQ)

90. The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival. (PubMed)

The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival. The objective of our study was to compare attenuation distribution across the long-axis (ADLA) measurements, Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, and Choi criteria for predicting overall survival (OS) in patients with metastatic breast cancer treated with bevacizumab.We obtained HIPAA-compliant data from a prospective

2018 AJR. American journal of roentgenology

91. Impact of Sodium Bicarbonate-Buffered Lidocaine on Patient Pain During Image-Guided Breast Biopsy. (PubMed)

Impact of Sodium Bicarbonate-Buffered Lidocaine on Patient Pain During Image-Guided Breast Biopsy. This randomized, double-blind controlled study evaluated the effectiveness of sodium bicarbonate-buffered lidocaine on reducing pain during imaging-guided breast biopsies.This prospective, HIPAA-compliant study randomly assigned 85 women undergoing ultrasound- or stereotactic-guided core-needle breast biopsies to receive intradermally and intraparenchymally either 1% lidocaine buffered with sodium

2018 Journal of the American College of Radiology : JACR

92. Patient Modesty: Volume 85

assumptions that it is no big deal because that is how things are done here... Make requests for same gender care, see how those requests are treated. You also stated: But I never hear gossip by other professionals and neither my patients regarding their observation of true sexual misbehavior or gross inattention, without remedy... Again I hope this is not too personal, and I am not asking you to violate HIPAA, but what gossip do you hear? The incident at the U of Pitt hospital was attributed to something (...) to be done at the national level and applicable to all 50 states. I've said before, I think the answer is legislation. I agree that it is sad that common sense and respect for others has to be legislated, but time and time again that has proven to be the case. I wish we didn't have to make new laws to correct what should have been done in the first place but there are times when such laws have been beneficial. Where to start? I'm not sure but let's take a look at HIPAA. I have yet to do research

2018 Bioethics Discussion Blog

93. Electronic Communication in Plastic Surgery: Guiding Principles from the American Society of Plastic Surgeons Health Policy Committee. (PubMed)

of these technologies.A search was performed on PubMed and the Cochrane database; terms included "telemedicine," "text messaging," "HIPAA," "metadata," "video conferencing," "photo sharing," "social media," "Facebook," "Twitter," and "Instagram." Initial screening of all identified articles was performed; the level of evidence, limitations, and recommendations were evaluated and articles were reviewed.A total of 654 articles were identified in the level I screening process; after more comprehensive review, 41

2018 Plastic and reconstructive surgery

94. What Happens after a Diagnosis of High-Risk Breast Lesion at Stereotactic Vacuum-assisted Biopsy? An Observational Study of Postdiagnosis Management and Imaging Adherence. (PubMed)

-approved HIPAA-compliant retrospective study included 208 patients who underwent stereotactic biopsy between January 2012 and December 2014 that revealed a high-risk lesion. Whether the patient underwent surgical excision and/or follow-up mammography was documented. Adherence of these women to a protocol of subsequent mammography within 1 year (9-18 months) or within 2 years (9-30 months) was compared with that of 45 508 women with normal screening mammograms who were imaged during the same time period

2018 Radiology

95. The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study. (PubMed)

The Incidental Splenic Mass at CT: Does It Need Further Work-up? An Observational Study. Purpose To evaluate whether an incidentally noted splenic mass at abdominal computed tomography (CT) requires further imaging work-up. Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective study, a search of a CT database was performed for patients with splenic masses at CT examinations of the abdomen and chest from 2002 to 2008. Patients were divided into three

2018 Radiology

96. Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

the study period. In the opinion of the investigator, subject is able to comply with the protocol, understand and sign an informed consent and HIPAA form. Subjects will be advised to refrain from major changes in their level of exercise during the study period. Men who meet any of the following criteria are NOT eligible for enrollment in the trial: Men participating in another clinical trial involving an investigational drug within the 30 days prior to the first screening visit. Men not living

2018 Clinical Trials

97. The Use of Oracea and Epiduo Forte in Severe Acne Patients

will not be required to practice a reliable method of contraception. These subjects may be enrolled at the Investigator's discretion if they are counseled to remain sexually inactive during the study and understand the possible risks in getting pregnant during the study.] ii. Facial acne IGA score of 4 iii. Minimum of 20 or more inflammatory lesions and 20 or more non-inflammatory lesions and not more than 4 nodules iv. Able to understand the requirements of the study and sign Informed Consent/HIPAA Authorization

2018 Clinical Trials

98. Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately. Age ≥ 18 years at the time of consent (no upper age limit) Eastern Cooperative Oncology Group (ECOG) Performance Status of ≤ 2 (see Section 10.1 Appendix A) Tumor Eligibility: Dose escalation cohorts: Histologically confirmed advanced solid tumor

2018 Clinical Trials

99. Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.

. Parent/LAR Is 18 years of age or older and willing/able to present proof of guardianship for the infant subject (i.e., birth certificate, hospital records, adoption record, insurance card, other ID along with valid ID of parent/LAR). Parent/LAR has signed the ICD including Health Insurance Portability and Accountability Act (HIPAA) disclosure in English, for the infant to participate in the study. Parent/LAR agrees not to introduce any new products or fragrances on his/her person, on his/her infant

2018 Clinical Trials

100. Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis

have no known allergy to riluzole or inactive ingredients* in ROSF. Subjects or subject's legally authorized representative must be willing and able to complete informed consent/assent and HIPAA authorization. Ability to comprehend and be informed of the nature of the study, as assessed by the Primary or Sub-Investigator. Subjects prescribed to take riluzole at or before the time of first dose. (The study is open to subjects currently taking riluzole at screening, subjects who are not currently

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>